Anti-PMEL Reference Antibody (Novartis patent anti-PMEL17)
- Product Code: 140425
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Used in targeted cancer therapies, particularly in melanoma treatment, due to its specific binding to PMEL17, a protein highly expressed in melanocytes and melanoma cells. This antibody serves as a key component in antibody-drug conjugates (ADCs), delivering cytotoxic agents directly to tumor cells while minimizing damage to healthy tissues. It is also utilized in diagnostic imaging to detect melanoma metastases. Its high specificity makes it valuable in research for studying melanin synthesis and melanocyte biology.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 10-20 days | £115.31 |
+
-
|
Anti-PMEL Reference Antibody (Novartis patent anti-PMEL17)
Used in targeted cancer therapies, particularly in melanoma treatment, due to its specific binding to PMEL17, a protein highly expressed in melanocytes and melanoma cells. This antibody serves as a key component in antibody-drug conjugates (ADCs), delivering cytotoxic agents directly to tumor cells while minimizing damage to healthy tissues. It is also utilized in diagnostic imaging to detect melanoma metastases. Its high specificity makes it valuable in research for studying melanin synthesis and melanocyte biology.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
£0.00
£0.00
Total :